Comprehensive health services

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationDuvelisib (IPI-145, INK1197) is a novel and selectivePI3K δ/γinhibitor withKiandIC50of 23 pM/243 pM and 1 nM/50 nM in cell-free assays, highly selective for PI3K δ/γ than other protein kinases. Phase 3.In vitroIPI-145 suppresses

InformationC-215 is a novel mycobacterial membrane protein large 3 (MmpL3) inhibitor with MIC90 of 16 uM against M. tuberculosis.

InformationC-215 is a novel mycobacterial membrane protein large 3 (MmpL3) inhibitor with MIC90 of 16 uM against M. tuberculosis.

Potentiator of NMDA receptors containing GluN2C/GluN2D.

Potentiator of NMDA receptors containing GluN2C/GluN2D.

Potentiator of NMDA receptors containing GluN2C/GluN2D.

Potentiator of NMDA receptors containing GluN2C/GluN2D.

DOWEX MARATHON WGA.

DOWEX MARATHON WGA.